Deep Medicine Acquisition (Deep Medicine Acquisition) Current Accrued Expense : $1.26 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Current Accrued Expense?

Deep Medicine Acquisition's Current Accrued Expense for the quarter that ended in Sep. 2023 was $1.26 Mil.

Deep Medicine Acquisition's quarterly Current Accrued Expense increased from Mar. 2023 ($0.87 Mil) to Jun. 2023 ($1.17 Mil) and increased from Jun. 2023 ($1.17 Mil) to Sep. 2023 ($1.26 Mil).

Deep Medicine Acquisition's annual Current Accrued Expense declined from Mar. 2021 ($0.04 Mil) to Mar. 2022 ($0.04 Mil) but then increased from Mar. 2022 ($0.04 Mil) to Mar. 2023 ($0.87 Mil).

Deep Medicine Acquisition Current Accrued Expense Historical Data

The historical data trend for Deep Medicine Acquisition's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Current Accrued Expense Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

Current Accrued Expense

0.04

0.87

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Current Accrued Expense	Get a 7-Day Free Trial							0.53	0.54	0.87	1.17	1.26

Deep Medicine Acquisition Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Deep Medicine Acquisition Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017